Clinical trial
Effect of Botulinum Toxin in Neurogenic Bladders in Children With…
NCT00175123 · University of Aarhus, Other · Unknown status
Key facts
| NCT number | NCT00175123 |
|---|---|
| Title | Effect of Botulinum Toxin in Neurogenic Bladders in Children With Myelomeningocele |
| Official title | Phase 4 Study of the Effect of Botulinum-A Toxin Injected in Neurogenic Overactive Bladders of Children Born With Myelomeningocele |
| Lead sponsor | University of Aarhus, Other |
| Collaborators | Aarhus University Hospital |
| Status | Unknown status |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Myelomeningocele, Bladder, Neurogenic |
| Intervention type | Drug |
| Interventions | Botulinum A toxin |
| Enrollment | 30 |
| Start date | May 1, 2005 |
| Primary completion | Mar 1, 2008 |
| Completion | Jun 1, 2008 |
| First posted | Sep 15, 2005 |
| Last update posted | Feb 20, 2009 |
| Countries | Denmark |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: